Literature DB >> 23812841

Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival.

Derrick D Kao1, Scott R Oldebeken, Anjali Rai, Edith Lubos, Jane A Leopold, Joseph Loscalzo, Diane E Handy.   

Abstract

We investigated the effects of tumor necrosis factor-α (TNF-α) exposure on mitogen-activated protein kinase signaling in human microvascular endothelial cells. TNF-α caused a significant suppression of a dual specificity phosphatase, DUSP4, that regulates ERK1/2 activation. Thus, we hypothesized that suppression of DUSP4 enhances cell survival by increasing ERK1/2 signaling in response to growth factor stimulation. In support of this concept, TNF-α pre-exposure increased growth factor-mediated ERK1/2 activation, whereas overexpression of DUSP4 with an adenovirus decreased ERK1/2 compared to an empty adenovirus control. Overexpression of DUSP4 also significantly decreased cell viability, lessened recovery in an in vitro wound healing assay, and decreased DNA synthesis. Pharmacological inhibition of NFκB activation or a dominant negative construct of the inhibitor of κB significantly lessened TNF-α-mediated suppression of DUSP4 expression by 70-84% and attenuated ERK activation, implicating NFκB-dependent pathways in the TNF-α-mediated suppression of DUSP4 that contributes to ERK1/2 signaling. Taken together, our findings show that DUSP4 attenuates ERK signaling and reduces cell viability, suggesting that the novel crosstalk between NFκB and MAPK pathways contributes to cell survival.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23812841      PMCID: PMC3772965          DOI: 10.1007/s11010-013-1730-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

Review 1.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation.

Authors:  Jinhwa Lee; Feng Hong; Sijoong Kwon; Sam Soo Kim; Dong Ok Kim; Heung Sun Kang; Su Jae Lee; Joohun Ha; Sung Soo Kim
Journal:  Biochem Biophys Res Commun       Date:  2002-11-15       Impact factor: 3.575

Review 4.  Relevance of new drug discovery to reduce NF-κB activation in cardiovascular disease.

Authors:  Rosalinda Madonna; Raffaele De Caterina
Journal:  Vascul Pharmacol       Date:  2012-02-17       Impact factor: 5.773

5.  Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.

Authors:  C Tournier; P Hess; D D Yang; J Xu; T K Turner; A Nimnual; D Bar-Sagi; S N Jones; R A Flavell; R J Davis
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

Review 6.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

7.  Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation.

Authors:  Edith Lubos; Neil J Kelly; Scott R Oldebeken; Jane A Leopold; Ying-Yi Zhang; Joseph Loscalzo; Diane E Handy
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

8.  p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2.

Authors:  Song-Ping Li; Melissa R Junttila; Jiahuai Han; Veli-Matti Kähäri; Jukka Westermarck
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

9.  Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.

Authors:  Justin M Balko; Rebecca S Cook; David B Vaught; María G Kuba; Todd W Miller; Neil E Bhola; Melinda E Sanders; Nara M Granja-Ingram; J Joshua Smith; Ingrid M Meszoely; Janine Salter; Mitch Dowsett; Katherine Stemke-Hale; Ana M González-Angulo; Gordon B Mills; Joseph A Pinto; Henry L Gómez; Carlos L Arteaga
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

10.  Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1.

Authors:  Y Liu; M W Mayo; A S Nagji; P W Smith; C S Ramsey; D Li; D R Jones
Journal:  Oncogene       Date:  2011-07-18       Impact factor: 9.867

View more
  10 in total

1.  EphA2 stimulates VCAM-1 expression through calcium-dependent NFAT1 activity.

Authors:  Steven Daniel Funk; Alexandra C Finney; Arif Yurdagul; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Signal       Date:  2018-05-21       Impact factor: 4.315

2.  Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress.

Authors:  Alma Barajas-Espinosa; Ariel Basye; Mark G Angelos; Chun-An Chen
Journal:  Free Radic Biol Med       Date:  2015-07-14       Impact factor: 7.376

3.  Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

Authors:  Hui Chen; Jing Pan; Jin-Dan Wang; Qiu-Mei Liao; Xiao-Ru Xia
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  Immunometabolic Endothelial Phenotypes: Integrating Inflammation and Glucose Metabolism.

Authors:  Wusheng Xiao; William M Oldham; Carmen Priolo; Arvind K Pandey; Joseph Loscalzo
Journal:  Circ Res       Date:  2021-04-23       Impact factor: 17.367

5.  Tyrosine phosphorylation allows integration of multiple signaling inputs by IKKβ.

Authors:  April N Meyer; Kristine A Drafahl; Christopher W McAndrew; Jennifer E Gilda; Leandro H Gallo; Martin Haas; Laurence M Brill; Daniel J Donoghue
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

6.  Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.

Authors:  Jun-Chieh J Tsay; Zhiguo Li; Ting-An Yie; Feng Wu; Leopoldo Segal; Alissa K Greenberg; Eric Leibert; Michael D Weiden; Harvey Pass; John Munger; Alexander Statnikov; Kam-Meng Tchou-Wong; William N Rom
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

7.  Dual-Specificity Phosphatase 4 Overexpression in Cells Prevents Hypoxia/Reoxygenation-Induced Apoptosis via the Upregulation of eNOS.

Authors:  Julie A Dougherty; Joanna Kilbane Myers; Mahmood Khan; Mark G Angelos; Chun-An Chen
Journal:  Front Cardiovasc Med       Date:  2017-04-24

8.  11,12 Epoxyeicosatrienoic Acid Rescues Deteriorated Wound Healing in Diabetes.

Authors:  Katharina Sommer; Heike Jakob; Caroline Reiche; Dirk Henrich; Jasmina Sterz; Johannes Frank; Ingo Marzi; Anna Lena Sander
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

9.  Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK.

Authors:  Naru Morita; Toshio Hosaka; Atsuko Kitahara; Toshitaka Murashima; Hirohisa Onuma; Yoshikazu Sumitani; Kazuto Takahashi; Toshiaki Tanaka; Takuma Kondo; Hitoshi Ishida
Journal:  J Diabetes Res       Date:  2018-03-11       Impact factor: 4.011

10.  Oral Selumetinib Does Not Negatively Impact Photoreceptor Survival in Murine Experimental Retinal Detachment.

Authors:  Colleen M Cebulla; Bongsu Kim; Valerie George; Tyler Heisler-Taylor; Sumaya Hamadmad; Alana Y Reese; Shaili S Kothari; Rania Kusibati; Hailey Wilson; Mohamed H Abdel-Rahman
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.